Disc Medicine to Participate in the Jefferies Global Healthcare Conference

WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will give a corporate presentation at the Jefferies Global Healthcare Conference on Thursday, June 6^th at 1:00 pm ET.

A live webcast of the presentation will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.

About Disc

Disc Medicine (NASDAQ: IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.

Media Contact

Peg Rusconi
Verge Scientific Communications
[email protected]

Investor Relations Contact

Christina Tartaglia
Stern Investor Relations
[email protected]

You May Also Be Interested In

• Brandywine Realty Trust Announces Expiration of Tender Offer for the 2028 Notes
• New Crypto Pepeto Announces Crossing 41,000 Buyers Fast as the BNB Price Prediction Targets $1,755
• Metropolitan Issues Statement on Release of 2027-2028 Guidelines, ROD for Colorado River Operations